These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 21890691)

  • 1. Endothelial growth factor therapy improves preeclampsia-like manifestations in a murine model induced by overexpression of sVEGFR-1.
    Mateus J; Bytautiene E; Lu F; Tamayo EH; Betancourt A; Hankins GD; Longo M; Saade GR
    Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H1781-7. PubMed ID: 21890691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term maternal cardiovascular function in a mouse model of sFlt-1-induced preeclampsia.
    Bytautiene E; Lu F; Tamayo EH; Hankins GD; Longo M; Kublickiene K; Saade GR
    Am J Physiol Heart Circ Physiol; 2010 Jan; 298(1):H189-93. PubMed ID: 19915174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal serum-soluble vascular endothelial growth factor receptor-1 in early pregnancy ending in preeclampsia or intrauterine growth retardation.
    Wathén KA; Tuutti E; Stenman UH; Alfthan H; Halmesmäki E; Finne P; Ylikorkala O; Vuorela P
    J Clin Endocrinol Metab; 2006 Jan; 91(1):180-4. PubMed ID: 16263826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia.
    Ahmad S; Ahmed A
    Circ Res; 2004 Oct; 95(9):884-91. PubMed ID: 15472115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renin-angiotensin system transgenic mouse model recapitulates pathophysiology similar to human preeclampsia with renal injury that may be mediated through VEGF.
    Denney JM; Bird C; Gendron-Fitzpatrick A; Sampene E; Bird IM; Shah DM
    Am J Physiol Renal Physiol; 2017 Mar; 312(3):F445-F455. PubMed ID: 27927648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate.
    Romero R; Nien JK; Espinoza J; Todem D; Fu W; Chung H; Kusanovic JP; Gotsch F; Erez O; Mazaki-Tovi S; Gomez R; Edwin S; Chaiworapongsa T; Levine RJ; Karumanchi SA
    J Matern Fetal Neonatal Med; 2008 Jan; 21(1):9-23. PubMed ID: 18175241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of pravastatin on angiogenic and placental hypoxic imbalance in a mouse model of preeclampsia.
    Saad AF; Kechichian T; Yin H; Sbrana E; Longo M; Wen M; Tamayo E; Hankins GD; Saade GR; Costantine MM
    Reprod Sci; 2014 Jan; 21(1):138-45. PubMed ID: 23749761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using pravastatin to improve the vascular reactivity in a mouse model of soluble fms-like tyrosine kinase-1-induced preeclampsia.
    Costantine MM; Tamayo E; Lu F; Bytautiene E; Longo M; Hankins GDV; Saade GR
    Obstet Gynecol; 2010 Jul; 116(1):114-120. PubMed ID: 20567176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor attenuates Nomega-nitro-L-arginine methyl ester-induced preeclampsia-like manifestations in rats.
    Chen D; Wang H; Huang H; Dong M
    Clin Exp Hypertens; 2008 Oct; 30(7):606-15. PubMed ID: 18855264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential responses of mesenteric arterial bed to vasoactive substances in L-NAME-induced preeclampsia: Role of oxidative stress and endothelial dysfunction.
    Amaral TAS; Ognibene DT; Carvalho LCRM; Rocha APM; Costa CA; Moura RS; Resende AC
    Clin Exp Hypertens; 2018; 40(2):126-135. PubMed ID: 28726518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of sildenafil on the altered thoracic aorta smooth muscle responses in rat pre-eclampsia model.
    Turgut NH; Temiz TK; Bagcivan I; Turgut B; Gulturk S; Karadas B
    Eur J Pharmacol; 2008 Jul; 589(1-3):180-7. PubMed ID: 18538317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of prenatal pravastatin treatment on altered fetal programming of postnatal growth and metabolic function in a preeclampsia-like murine model.
    McDonnold M; Tamayo E; Kechichian T; Gamble P; Longo M; Hankins GD; Saade GR; Costantine MM
    Am J Obstet Gynecol; 2014 Jun; 210(6):542.e1-7. PubMed ID: 24412113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of over-expression of sFlt-1 on blood pressure and the occurrence of other manifestations of preeclampsia in unrestrained conscious pregnant mice.
    Lu F; Longo M; Tamayo E; Maner W; Al-Hendy A; Anderson GD; Hankins GD; Saade GR
    Am J Obstet Gynecol; 2007 Apr; 196(4):396.e1-7; discussion 396.e7. PubMed ID: 17403433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of VEGF and its soluble receptor VEGFR-1 in preterm newborns of preeclamptic mothers with RDS.
    Kalay S; Cakcak B; Oztekin O; Tezel G; Tosun O; Akcakus M; Oygur N
    J Matern Fetal Neonatal Med; 2013 Jul; 26(10):978-83. PubMed ID: 23339636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low maternal concentrations of soluble vascular endothelial growth factor receptor-2 in preeclampsia and small for gestational age.
    Chaiworapongsa T; Romero R; Gotsch F; Espinoza J; Nien JK; Goncalves L; Edwin S; Kim YM; Erez O; Kusanovic JP; Pineles BL; Papp Z; Hassan S
    J Matern Fetal Neonatal Med; 2008 Jan; 21(1):41-52. PubMed ID: 18175243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pravastatin Effects on Placental Prosurvival Molecular Pathways in a Mouse Model of Preeclampsia.
    Saad AF; Diken ZM; Kechichian TB; Clark SM; Olson GL; Saade GR; Costantine MM
    Reprod Sci; 2016 Nov; 23(11):1593-1599. PubMed ID: 27170663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia.
    Koga K; Osuga Y; Yoshino O; Hirota Y; Ruimeng X; Hirata T; Takeda S; Yano T; Tsutsumi O; Taketani Y
    J Clin Endocrinol Metab; 2003 May; 88(5):2348-51. PubMed ID: 12727995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The relativity of vascular endothelium growth factor receptor-1 and preeclampsia].
    Zou CL; Liu XH; Yue BM; Fu JH; He GL
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Sep; 37(5):765-8. PubMed ID: 17037747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of recombinant placental growth factor 2 on hypertension induced by full-length mouse soluble fms-like tyrosine kinase 1 adenoviral vector in pregnant mice.
    Suzuki H; Ohkuchi A; Matsubara S; Takei Y; Murakami M; Shibuya M; Suzuki M; Sato Y
    Hypertension; 2009 Nov; 54(5):1129-35. PubMed ID: 19786649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uterine vascular function in a transgenic preeclampsia rat model.
    Verlohren S; Niehoff M; Hering L; Geusens N; Herse F; Tintu AN; Plagemann A; LeNoble F; Pijnenborg R; Muller DN; Luft FC; Dudenhausen JW; Gollasch M; Dechend R
    Hypertension; 2008 Feb; 51(2):547-53. PubMed ID: 18195162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.